ISRCTN84445406
Completed
未知
STHLM3 - Prostate cancer diagnostic randomized trial
Karolinska Institutet (Sweden)0 sites140,000 target enrollmentJanuary 3, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Karolinska Institutet (Sweden)
- Enrollment
- 140000
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26563502 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36185581/ (added 04/10/2022)
Investigators
Eligibility Criteria
Inclusion Criteria
- •All men between 50 and 69 years of age who have a permanent postal address in Stockholm County Council or Region Gotland (N\=260,000\) will be asked whether they would like to take part in STHLM3\.
Exclusion Criteria
- •Diagnosed with prostate cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
STHLM3 - Prostate Cancer Diagnostic TrialProstate CancerNCT03639649Karolinska Institutet58,818
Completed
Not Applicable
STHLM3-MR: Comparing Standard With Targeted Prostate BiopsiesProstate CancerNCT02788825Karolinska Institutet687
Active, not recruiting
Not Applicable
Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion BiopsiesProstate CancerNCT03377881Karolinska Institutet12,750
Completed
Not Applicable
Prostate cancer screening trial using imagingISRCTN43502108Imperial College London408
Active, not recruiting
Phase 3
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate CancerProstate CancerNCT03531099Hospices Civils de Lyon108